PD-L1
13 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial. (NCT05397769) | Sun Yat-sen University | 2022-06-08 |
| PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor (NCT05156515) | Peking University Cancer Hospital & Institute | 2021-12-09 |
| PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment (NCT04634058) | Shanghai Zhongshan Hospital | 2021-03-26 |
| Immune Profiling After HDR in Local Relapsed Prostate Cancer (NCT04247217) | Maastricht Radiation Oncology | 2020-02-19 |
| Genetic Mutation in Epithelial Ovarian Cancer (NCT04191252) | Lei Li | 2019-12-19 |
| Genetic Mutation in Recurrent Cervical Cancer (NCT04191226) | Lei Li | 2019-12-19 |
| Effect of Chemotherapy on PD-L1 in NSCLC (NCT03701607) | Baodong Qin | 2018-09-01 |
Track PD-L1 automatically
Every clearance here is in the API, with alerts when new ones post.